Crestor (Rosuvastatin) (Crestor 20 mg) and Evolocumab: interaction and safety
This source-based reference is not a personal treatment recommendation. The relevance and management of an interaction depend on the exact products, route, dose and clinical situation.
Interaction mechanism
Statins may increase PCSK9 production and evolocumab clearance; the observed lipid response remained intact.
Clinical significance and safety
Crestor (Rosuvastatin) and Evolocumab: Evolocumab and a statin may be deliberately prescribed together. The studied clearance change did not require a statin adjustment solely because evolocumab was added. Follow the clinician-directed treatment and LDL monitoring. This finding is not a harmful-interaction warning or a reason to stop the statin.
Using this information
This is a source-based reference record, not a recommendation to combine, stop or change medicines. A missing interaction record does not establish safe use. A qualified healthcare professional should consider the exact products, doses, other medicines and individual health circumstances.